Patient dosing has commenced in a combination study of Bria-IMT with KEYTRUDA or YERVOY in advanced breast cancer Company recently announced positive proof of concept data in the Phase I/IIa study of Bria-IMT in advanced breast cancer patients, which indicated excellent targeted anti-tumor activity and outstanding safety and tolerability KEYTRUDA and YERVOY are highly recognized for their potent […]
The Stocks To Buy Now Blog
Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.